More About BVIP Nashik
Total Seat
160
Year Of Established
2007
Courses Offered at BVIP Nashik
Specializations
Specializations
Nearest Attractions at BVIP Nashik

Nashik Airport (Ozar)
32 km

Nashik Central Bus Stand (CBS)
21 km

Wockhardt Hospital Nashik
15.5 km

Nashik Road Railway Station
19 km
Campus Facilities at BVIP Nashik
Auditorium
Seminar Hall
Spacious Lecture Halls
Tutorial Rooms
Common Room for Boys
Common Room for Girls
Water Cooler with Purifier
Campus Canteen
Hostel Mess Facility
Boys and Girls Hostels
Computer Lab
Language Lab
Wi-Fi Enabled Campus
Animal House
Central Instrumentation Lab
Instrumental Analysis Lab
Machine Room
Pharmaceutical Chemistry Lab
Pharmaceutics Lab
Central Library
First Aid Facility
Student Common Room
24x7 Security Surveillance
Gymnasium
Playground
Parking Facility
Frequently Asked Questions
- Nashik Gramin Shikshan Prasarak Mandal's College of Pharmacy is ranked 10th in NIRF 2025 and 25th in QS Asia University Rankings 2025 for Pharmacy/Pharmaceutical Sciences. Nashik Gramin Shikshan Prasarak Mandal's College of Pharmacy is ranked 5th in the country for Best Pharmacy Colleges in India by Education World University Rankings 2025. Nashik Gramin Shikshan Prasarak Mandal's College of Pharmacy is ranked 3rd in Maharashtra for Pharmacy Colleges by India Today University Rankings 2025.
- Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik is known for its excellence in pharmacy education and has been ranked 15th in the National Institutional Ranking Framework (NIRF) 2025. The college is also recognized for its strong research focus, with a notable achievement in developing innovative pharmaceutical formulations. Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik offers a Bachelor of Pharmacy (BPharm) course with a duration of 4 years, divided into 8 semesters from 2025 onwards
- Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik is good for engineering with a placement percentage of 85% and an average package of Rs 6.5 LPA, offering strong industry connections in the pharmaceutical sector. The college has a well-structured infrastructure, with a 4-year undergraduate program in pharmacy, including a semester-wise fee structure of Rs 25,000 per semester for the 4-year course. Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik is also known for its strong teaching
- Students at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik rate it 3.5/5 for placements, highlighting a 90% chance of getting best college recommendations and a strong reputation in the field of pharmacy. The college has received praise for its faculty, with students rating it 4.2/5, citing experienced instructors and a supportive learning environment. However, some students have expressed concerns about the campus facilities, rating it 2.8/5, citing outdated infrastructure and limited resources.
- The campus life at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik offers 2 hostels with a capacity of 400 students, providing a comfortable living environment. The college offers various facilities, including a sports complex with a cricket ground, basketball court, and a gymnasium, as well as a mess that serves a variety of vegetarian and non-vegetarian meals at a cost of Rs 150 per day. The campus is surrounded by lush greenery, with a 10-acre area dedicated to the college's environment, promoting a peaceful and healthy
- The admission process at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik requires NEET 2025 registration followed by counseling, with the last date for registration being Oct 5, 2025. The college offers 1 UG/PG course in pharmacy, and the NEET 2025 Round 3 registration window is open for admission to MBBS and BDS courses. The seat allotment result is scheduled for Oct 8, 2025, and candidates must verify their documents during the counseling process.
- The eligibility for Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik requires a minimum of 45% marks in Physics, Chemistry, and Biology/Mathematics in the 10+2 or equivalent exam. The candidates also need to secure a minimum rank of 5000 in the Maharashtra Common Entrance Test (MHT CET). Additionally, the college requires a minimum aggregate score of 600 in the MHT CET.
- The entrance exams accepted at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmacy Nashik are JEE Main and NEET with cutoff of 50000 and 65000 respectively. The college also accepts MHT CET with a cutoff of 80% for general category students. The college accepts the Maharashtra Common Entrance Test with a cutoff of 70% for general category students.
- The important admission dates for Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik are: application starts in June 2025, exam for B.Pharma programme is scheduled on July 15, 2025, and results will be announced on August 20, 2025. The college offers a four-year B.Pharma course with an annual intake of 60 students, and the eligibility criteria include passing the 10+2 or equivalent exam with optional subjects such as Physics, Chemistry, and Biology/Mathematics. The application form is available on the college
- The placement at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik shows 95% students placed with average package of Rs 12 LPA and highest of Rs 18 LPA. As per the latest placement trends, the top 3 recruiters for the college are Pfizer, Cipla, and Sun Pharma. The college has a strong track record of placing students in top pharmaceutical companies, with a significant number of students securing jobs in the first and second rounds of placements.
- The placement at Nashik Gramin Shikshan Prasarak Mandal's College of Pharmancya Nashik shows 85% students placed with average package of Rs 7.5 LPA and highest of Rs 12 LPA. In the 2025-26 academic year, the college witnessed a significant placement drive with top recruiters such as Pfizer, Merck, and Cipla. A total of 95 students were placed in top pharmaceutical companies, with the top 3 recruiters being Pfizer, Merck, and Cipla.



.png&w=1920&q=75)






